Bristol-Myers Squibb Company (BMY) financial statements and ratios from SEC XBRL: revenue $48.19B (TTM), net margin 14.6%, revenue growth 5.7% YoY, P/E 14.4. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $48.19B |
| Net Margin | 14.6% |
| Revenue Growth (YoY) | 5.7% |
| EPS Growth (YoY) | 153.1% |
| FCF Growth (YoY) | -13.2% |
| P/E Ratio | 14.4 |
| EV / EBITDA | 10.9 |
| Price / Book | 5.99 |
| Price / Sales | 2.72 |
| FCF Yield | 8.6% |
| DCF Value (model) | $20.91 |
| DCF Upside vs Price | -68.1% |
| Altman Z-Score | 2.34 (grey) |
| Piotroski F-Score | 8/9 |
| Sector P/E (Healthcare) | 21.6 |
BMY overview · BMY earnings · BMY KPIs · BMY investor relations · BMY ownership · BMY peers · BMY filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.